Concepedia

Nawar Diar Bakerly

ND

37

Publications

4.1K

Citations

24

H-Index

2008

Active since

Affiliations

Salford Royal NHS Foundation Trust(Current)

University of Manchester

Manchester Academic Health Science Centre

Manchester University NHS Foundation Trust

GlaxoSmithKline (United Kingdom)

Nawar Diar Bakerly is an author at Salford Royal NHS Foundation Trust specializing in medicine, public health, and covid-19.

Top concepts

MedicinePublic HealthCovid-19Clinical TrialsEpidemiologyHealth PolicyPatient SafetyHospital MedicineInfection ControlOutcomes Research

Publications per year

2008–2024

37

Publications

37

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

Rachael A Evans, Hamish McAuley, Ewen M. Harrison et al. · The Lancet Respiratory Medicine · 2021 · 636 citations · Full text

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Rows per page

1–5 of 37